Wan Xiaoyang, Soni Krishnakant G, Choi Jong Min, Jung Sun Yun, Conner Margaret E, Preidis Geoffrey A
Division of Gastroenterology, Hepatology & Nutrition, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, United States.
Advanced Technology Core, Mass Spectrometry Proteomics Core, Baylor College of Medicine, Houston, Texas, United States.
Am J Physiol Gastrointest Liver Physiol. 2025 Jul 1;329(1):G232-G243. doi: 10.1152/ajpgi.00153.2025. Epub 2025 Jun 25.
Malnutrition decreases intestinal bile acids, resulting in inefficient nutrient absorption and impaired catch-up growth. Mechanisms by which bile acid depletion occurs in malnutrition are unknown. Using a mouse model of early-life malnutrition, we explored bile acid homeostasis, focusing on transcriptional repression of oxysterol 7α-hydroxylase (CYP7B1), a rate-limiting enzyme in the alternative pathway of bile acid biosynthesis, by sterol regulatory element-binding protein-1c (SREBP-1c), a master regulator of lipid metabolism. Mice were maintained on a low-protein, low-fat, or isocaloric control chow until 8 wk of age, when livers were harvested for proteome profiling, western blot, reverse transcription quantitative real-time PCR, and chromatin immunoprecipitation. Cultured hepatocytes and mice were treated with the SREBP-1c inhibitors fatostatin and betulin to determine whether this therapeutic strategy rescues CYP7B1 expression and bile acid synthesis in malnutrition. Malnutrition decreased the bile acid pool size and altered the expression of multiple hepatic cytochrome P450 enzymes, with profound depletion of CYP7B1, in males but not females. Malnutrition activated SREBP-1c and led to its enrichment at a gene regulatory region that featured loss of binding by the basal transcriptional activator specificity protein 1 (SP1). Treatment of cultured hepatocytes or malnourished mice with the SREBP-1c inhibitors fatostatin or betulin increased CYP7B1 expression. Both drugs rescued the bile acid pool size in malnourished mice. These results suggest that malnutrition impairs bile acid synthesis via transcriptional repression of by SREBP-1c. SREBP-1c inhibitors restore hepatic CYP7B1 expression and bile acid synthesis. We applied liver proteomics to a unique mouse model of early-life malnutrition to reveal a novel mechanism of suppression of bile acid synthesis. Malnutrition activates the nuclear protein SREBP-1c, which displaces the transcriptional activator SP1 from the promoter of the gene. Two different SREBP-1c inhibitors rescue CYP7B1 expression in vitro and rescue the bile acid pool in malnourished mice. This discovery might facilitate novel adjunct therapies to enhance nutritional rehabilitation in malnourished children.
营养不良会减少肠道胆汁酸,导致营养吸收效率低下和追赶生长受损。营养不良时胆汁酸耗竭的机制尚不清楚。我们使用早期营养不良的小鼠模型,探索胆汁酸稳态,重点研究固醇调节元件结合蛋白1c(SREBP-1c)对氧甾醇7α-羟化酶(CYP7B1)的转录抑制作用,CYP7B1是胆汁酸生物合成替代途径中的限速酶,而SREBP-1c是脂质代谢的主要调节因子。将小鼠饲养在低蛋白、低脂或等热量对照饲料中,直至8周龄,此时采集肝脏进行蛋白质组分析、蛋白质印迹、逆转录定量实时PCR和染色质免疫沉淀。用SREBP-1c抑制剂法托司他汀和桦木醇处理培养的肝细胞和小鼠,以确定这种治疗策略是否能挽救营养不良时的CYP7B1表达和胆汁酸合成。营养不良会减少雄性而非雌性小鼠的胆汁酸池大小,并改变多种肝细胞色素P450酶的表达,导致CYP7B1显著耗竭。营养不良会激活SREBP-1c,并导致其在一个基因调控区域富集,该区域的基础转录激活因子特异性蛋白1(SP1)的结合缺失。用SREBP-1c抑制剂法托司他汀或桦木醇处理培养的肝细胞或营养不良的小鼠,可增加CYP7B1表达。两种药物都能挽救营养不良小鼠的胆汁酸池大小。这些结果表明,营养不良通过SREBP-1c的转录抑制作用损害胆汁酸合成。SREBP-1c抑制剂可恢复肝脏CYP7B1表达和胆汁酸合成。我们将肝脏蛋白质组学应用于独特的早期营养不良小鼠模型,以揭示抑制胆汁酸合成的新机制。营养不良会激活核蛋白SREBP-1c,它会从该基因的启动子上取代转录激活因子SP1。两种不同的SREBP-1c抑制剂在体外可挽救CYP7B1表达,并在营养不良的小鼠中挽救胆汁酸池。这一发现可能有助于开发新的辅助疗法,以加强营养不良儿童的营养康复。